Amedeo Smart

Free Medical Literature Service




  Free Subscription

Articles published in
    August 2021
  1. SALINAS CISNEROS G, Webb J, Luban NLC, Nickel RS, et al
    Impact of universal irradiation on chronic transfusion for sickle cell disease.
    Transfusion. 2021;61:2290-2294.
    >> Share

  2. CHIDAMBARAM V, Jones JM, Lokhandwala PM, Bloch EM, et al
    Low rates of transfusion-transmitted infection screening in chronically transfused adults with sickle cell disease.
    Transfusion. 2021;61:2421-2429.
    >> Share

  3. MUNIZ JG, Arnoni C, Medeiros R, Vendrame T, et al
    Antigen matching for transfusion support in Brazilian female patients with sickle cell disease to reduce RBC alloimmunization.
    Transfusion. 2021;61:2458-2467.
    >> Share

  4. RANKIN A, Darbari D, Campbell A, Webb J, et al
    Screening for new red blood cell alloantibodies after transfusion in patients with sickle cell disease.
    Transfusion. 2021;61:2255-2264.
    >> Share

    July 2021
  5. CAHILL CM, Alhasson B, Blumberg N, Melvin A, et al
    Preoperative anemia management program reduces blood transfusion in elective cardiac surgical patients, improving outcomes and decreasing hospital length of stay.
    Transfusion. 2021 Jul 15. doi: 10.1111/trf.16564.
    >> Share

  6. SARKER TT, Delvadia B, Li S, Roback JD, et al
    Mizuho hemoglobinopathy, presenting with severe hemolytic anemia and multisystem organ failure secondary to exertion.
    Transfusion. 2021 Jul 1. doi: 10.1111/trf.16522.
    >> Share

  7. HASAN RA, Asif M, Tuott EE, Stansbury LG, et al
    Rates of delayed hemolytic transfusion reactions observed in a trauma center.
    Transfusion. 2021;61:2035-2040.
    >> Share

  8. GOWDA L, Vege S, Kessler D, Shaz B, et al
    Screening of blood donors for sickle cell trait using a DNA-based approach: Frequency in a multiethnic donor population.
    Transfusion. 2021;61:2008-2013.
    >> Share

    June 2021
  9. GAMBERINI MR, Fortini M, Stievano A, Calori E, et al
    Impact of the preparation method of red cell concentrates on transfusion indices in thalassemia patients: A randomized crossover clinical trial.
    Transfusion. 2021;61:1729-1739.
    >> Share

  10. GODBEY EA, Anderson MR, M Bachmann L, Sanford KW, et al
    How do we monitor hemoglobin S in patients who undergo red blood cell exchange and take voxelotor?
    Transfusion. 2021;61:1680-1683.
    >> Share

  11. BAROUQA M, Szymanski J, Nelson R, Jofre S, et al
    Bone marrow necrosis and fat embolism syndrome in sickle cell disease: A rapidly deteriorating complication.
    Transfusion. 2021;61:1678-1679.
    >> Share

    May 2021
  12. ANANDAPPA AJ, Stefely JA, Hasserjian RP, Dzik WH, et al
    Multiorgan failure in a fatal case of autoimmune hemolytic anemia.
    Transfusion. 2021 May 27. doi: 10.1111/trf.16513.
    >> Share

  13. LI S, He Z, Mo C, Ji Y, et al
    Hyporegenerative anemia in anti-M-associated hemolytic disease of the fetus.
    Transfusion. 2021 May 3. doi: 10.1111/trf.16350.
    >> Share

    A monthly roundup of key articles in other journals.
    Transfusion. 2021;61:1355-1358.
    >> Share

  15. GUARENTE J, Palladino M, Babariya S, Hayes C, et al
    Iatrogenic arteriovenous fistula in patient with sickle cell disease undergoing red blood cell exchange.
    Transfusion. 2021;61:1361-1362.
    >> Share

    April 2021
  16. THEMELIN N, Biston P, Massart J, Lelubre C, et al
    Effects of red blood cell transfusion on global oxygenation in anemic critically ill patients.
    Transfusion. 2021;61:1071-1079.
    >> Share

  17. JUSKEWITCH JE, Murray JD, Norgan AP, Moldenhauer SK, et al
    In from the cold: M-protein light chain glycosylation is positively associated with cold agglutinin titer levels.
    Transfusion. 2021;61:1302-1311.
    >> Share

    March 2021
  18. NGUYEN TN, Maenulein E, Fihman V, Vinatier I, et al
    Serologic characteristics of oxaliplatin antibodies in 15 patients with drug-induced immune hemolytic anemia.
    Transfusion. 2021 Mar 9. doi: 10.1111/trf.16360.
    >> Share

  19. ATAGA KI, Elsherif L, Wichlan D, Wogu AF, et al
    A pilot study of the effect of rivaroxaban in sickle cell anemia.
    Transfusion. 2021 Mar 4. doi: 10.1111/trf.16343.
    >> Share

    February 2021
  20. YATES B, Molloy E, Dulau-Florea A, Braylan R, et al
    Daratumumab for delayed RBC engraftment following major ABO mismatched haploidentical bone marrow transplantation.
    Transfusion. 2021 Feb 2. doi: 10.1111/trf.16281.
    >> Share

  21. DURIEUX-ROUSSEL E, Laget L, Filosa L, Izard C, et al
    RHCE*01 (c.499A>G, p.Met167Val) allele: Weak RhE expression which does not require the E-specific proline 226.
    Transfusion. 2021;61:E18-E20.
    >> Share

  22. ZIEMBA Y, Xu C, Fomani KM, Nandi V, et al
    Safety and benefits of automated red cell depletion-exchange compared to standard exchange in patients with sickle cell disease undergoing chronic transfusion.
    Transfusion. 2021;61:526-536.
    >> Share

  23. DINARDO CL, Oliveira TGM, Kelly S, Ashley-Koch A, et al
    Diversity of variant alleles encoding Kidd, Duffy, and Kell antigens in individuals with sickle cell disease using whole genome sequencing data from the NHLBI TOPMed Program.
    Transfusion. 2021;61:603-616.
    >> Share

  24. SLICHTER SJ, Gernsheimer T, LeBlanc R, Townsend-McCall D, et al
    Fecal blood loss: A quantitative method of evaluating hemostasis in patients with thrombocytopenia.
    Transfusion. 2021;61:393-403.
    >> Share

    January 2021
  25. ANDERSEN LH, Jacob EK, McThenia SS, Tauscher CD, et al
    Hemolytic disease and reticulocytopenia of the newborn attributable to maternal immunoglobulin G anti-M reacting optimally at cold temperatures.
    Transfusion. 2021 Jan 14. doi: 10.1111/trf.16252.
    >> Share

  26. SPENCER BR, Fox MP, Wise LA, Cable RG, et al
    Iron status and self-reported fatigue in blood donors.
    Transfusion. 2021;61:124-133.
    >> Share

  27. JUSKEWITCH JE, Zuccarelli MD, Berg HE, Summerfield DD, et al
    Transfusion medicine illustrated: When less is more for HLA antibodies.
    Transfusion. 2021;61:9-11.
    >> Share

    Donor iron depletion in context.
    Transfusion. 2021;61:318-321.
    >> Share

  29. RICHARDS AL, Qiu A, Zotti FD, Sheldon K, et al
    Autoantigen presentation by splenic dendritic cells is required for RBC-specific autoimmunity.
    Transfusion. 2021;61:225-235.
    >> Share

  30. SRIVASTAVA K, Albasri J, Alsuhaibani OM, Aljasem HA, et al
    SCAR: The high-prevalence antigen 013.008 in the Scianna blood group system.
    Transfusion. 2021;61:246-254.
    >> Share

  31. SAYERS M
    Donor iron nutrition: Which precaution prevails?
    Transfusion. 2021;61:313-317.
    >> Share

    December 2020
  32. JACOBS J, Eichbaum Q
    COVID-19 associated with severe autoimmune hemolytic anemia.
    Transfusion. 2020 Dec 3. doi: 10.1111/trf.16226.
    >> Share

  33. PAGANO MB, Cataife G, Fertrin KY, Gernsheimer T, et al
    Blood use and transfusion needs at a large health care system in Washington state during the SARS-CoV-2 pandemic.
    Transfusion. 2020;60:2859-2866.
    >> Share

    October 2020
  34. BEVERINA I, Scalvini R, Brando B
    "Camel humps"-shaped red blood cell histogram in a woman with extreme anemia treated with intravenous iron.
    Transfusion. 2020 Oct 28. doi: 10.1111/trf.16154.
    >> Share

  35. GARCIA-GARCIA I, Cid J, Palomino A, Gine E, et al
    Role of therapeutic plasma exchanges in refractory severe warm autoimmune hemolytic anemia: Presentation of two case reports.
    Transfusion. 2020 Oct 22. doi: 10.1111/trf.16143.
    >> Share

  36. STEUER LV, Kondo AT, Cipolletta AN, Sakashita AM, et al
    Predictive factors for the development of anemia after hematopoietic stem cell donation.
    Transfusion. 2020 Oct 14. doi: 10.1111/trf.16124.
    >> Share

  37. MAZZEFFI M, Taneja M, Porter S, Chow JH, et al
    Anemia, sex, and race as predictors of morbidity or mortality after knee arthroplasty surgery.
    Transfusion. 2020 Oct 5. doi: 10.1111/trf.16111.
    >> Share

    Mind the evidence gap: The need for trials in the prevention and management of perioperative anemia in noncardiac surgery.
    Transfusion. 2020;60:2168-2170.
    >> Share

    September 2020
  39. SANCHEZ-DURAN MA, Higueras MT, Aviles-Garcia M, Maiz N, et al
    Perinatal outcomes and central nervous system abnormalities following intrauterine fetal transfusion: 17 years' experience in a tertiary center.
    Transfusion. 2020 Sep 21. doi: 10.1111/trf.16087.
    >> Share

  40. NIZZI F, Rees M, Salzberg D, Ngwube A, et al
    Successful management of sirolimus toxicity in a hematopoietic stem cell transplant patient using automated red blood cell exchange.
    Transfusion. 2020 Sep 5. doi: 10.1111/trf.16064.
    >> Share

    August 2020
  41. ERSHLER WB, Holbrook ME
    Sickle Cell Anemia and COVID-19: Use of Voxelotor to Avoid Transfusion.
    Transfusion. 2020 Aug 19. doi: 10.1111/trf.16068.
    >> Share

  42. BLOCH EM, Branch HA, Sakac D, Leger RM, et al
    Differential red blood cell age fractionation and Band 3 phosphorylation distinguish two different subtypes of warm autoimmune hemolytic anemia.
    Transfusion. 2020 Aug 4. doi: 10.1111/trf.15911.
    >> Share

    July 2020
  43. BIBOULET P, Motais C, Pencole M, Karam O, et al
    Preoperative erythropoietin within a patient blood management program decreases both blood transfusion and postoperative anemia: a prospective observational study.
    Transfusion. 2020 Jul 18. doi: 10.1111/trf.15900.
    >> Share

  44. GUINN NR, Cooter ML, Maisonave Y, Grimsley A, et al
    How do I develop a process to effectively treat parturients with iron deficiency anemia?
    Transfusion. 2020 Jul 13. doi: 10.1111/trf.15930.
    >> Share

    IVIg and hemolytic anemia risk: dump the anti-A/B already!
    Transfusion. 2020;60:1337-1339.
    >> Share

    June 2020
  46. JERICO C, Beverina I, Quintana-Diaz M, Salvadori U, et al
    Efficacy and safety of high-dose intravenous iron as the first-choice therapy in outpatients with severe iron deficiency anemia.
    Transfusion. 2020 Jun 29. doi: 10.1111/trf.15870.
    >> Share

  47. WALLENHORST C, Patel A, Shebl A, Hubsch A, et al
    Anti-A/B isoagglutinin reduction in an intravenous immunoglobulin product and risk of hemolytic anemia: a hospital-based cohort study.
    Transfusion. 2020 Jun 2. doi: 10.1111/trf.15859.
    >> Share

    May 2020
  48. ZUMBERG M, Gorlin J, Griffiths EA, Schwartz G, et al
    A case study of 10 patients administered HBOC-201 in high doses over a prolonged period: outcomes during severe anemia when transfusion is not an option.
    Transfusion. 2020 May 1. doi: 10.1111/trf.15778.
    >> Share

    April 2020
  49. MAST AE, Langer JC, Guo Y, Bialkowski W, et al
    Genetic and behavioral modification of hemoglobin and iron status among first-time and high-intensity blood donors.
    Transfusion. 2020;60:747-758.
    >> Share

  50. SPENCER BR, Haynes JM, Notari EP 4th, Stramer SL, et al
    Prevalence, risk factors, and ferritin testing to mitigate iron depletion in male plateletpheresis donors.
    Transfusion. 2020;60:759-768.
    >> Share

  51. JAIME-PEREZ JC, Garcia-Salas G, Ancer-Rodriguez J, Gomez-Almaguer D, et al
    Audit of red blood cell transfusion in patients with acute leukemia at a tertiary care university hospital.
    Transfusion. 2020;60:724-730.
    >> Share

    March 2020
  52. BLOCH EM, Hull J, Green-Thompson R, Ingram C, et al
    Antenatal blood transfusion in South Africa: indications and practice in a high-HIV-prevalence setting.
    Transfusion. 2020;60:479-487.
    >> Share

  53. LIN DM, Becker J, Wu Y, Cooling L, et al
    How do I perform whole blood exchange?
    Transfusion. 2020;60:449-453.
    >> Share

    February 2020
  54. HINDAWI S, Badawi M, Elfayoumi R, Elgemmezi T, et al
    The value of transfusion of phenotyped blood units for thalassemia and sickle cell anemia patients at an academic center.
    Transfusion. 2020;60 Suppl 1:S15-S21.
    >> Share

  55. ELSHINAWY M, Kamal M, Nazir H, Khater D, et al
    Sepsis-related anemia in a pediatric intensive care unit: transfusion-associated outcomes.
    Transfusion. 2020;60 Suppl 1:S4-S9.
    >> Share

  56. BLATYTA PF, Kelly S, Sabino E, Preiss L, et al
    Prevalence of serologic markers of transfusion and sexually transmitted infections and their correlation with clinical features in a large cohort of Brazilian patients with sickle cell disease.
    Transfusion. 2020;60:343-350.
    >> Share

    January 2020
  57. GOLDSTEIN GP, Rao A, Ling AY, Ding VY, et al
    Influence of enteral feeding and anemia on tissue oxygen extraction after red blood cell transfusion in preterm infants.
    Transfusion. 2020 Jan 26. doi: 10.1111/trf.15680.
    >> Share

  58. GUDLAUGSSON B, Hjartardottir H, Svansdottir G, Gudmundsdottir G, et al
    Rhesus D alloimmunization in pregnancy from 1996 to 2015 in Iceland: a nation-wide population study prior to routine antenatal anti-D prophylaxis.
    Transfusion. 2020;60:175-183.
    >> Share

  59. VAN BUREN NL, Gorlin JB, Corby SM, Cassidy S, et al
    How do I incorporate red cell genotyping to improve chronic transfusion therapy?
    Transfusion. 2020;60:16-25.
    >> Share

  60. LEE LE, Beeler BW, Graham BC, Cap AP, et al
    Posttransfusion hyperhemolysis is arrested by targeting macrophage activation with novel use of Tocilizumab.
    Transfusion. 2020;60:30-35.
    >> Share

    December 2019
  61. JACKSON CHORNENKI NL, James TE, Barty R, Liu Y, et al
    Blood loss from laboratory testing, anemia, and red blood cell transfusion in the intensive care unit: a retrospective study.
    Transfusion. 2019 Dec 28. doi: 10.1111/trf.15649.
    >> Share

  62. COOLING L, Hugan S
    Daratumumab in combination with standard treatment for autoimmune hemolytic anemia in a pediatric patient.
    Transfusion. 2019;59:3801-3802.
    >> Share

    November 2019
  63. ROEHMEL J, Specht P, Staab D, Schwarz C, et al
    Risk of piperacillin-induced hemolytic anemia in patients with cystic fibrosis and antipseudomonal treatment: a prospective observational study.
    Transfusion. 2019 Nov 14. doi: 10.1111/trf.15591.
    >> Share

    Effect of anemia on muscle oxygen saturation during submaximal exercise.
    Transfusion. 2019 Nov 12. doi: 10.1111/trf.15588.
    >> Share

    October 2019
  65. CRISPIN P, Sliwinski K, Wilson C, Lennard S, et al
    Cold reacting anti-M causing delayed hemolytic disease of the newborn.
    Transfusion. 2019 Oct 31. doi: 10.1111/trf.15578.
    >> Share

  66. WEBB J
    The use of rejuvenated red blood cells for transfusion in patients with sickle cell anemia.
    Transfusion. 2019;59:3042-3045.
    >> Share

    September 2019
  67. BAHR TM, DuPont TL, Christensen TR, Rees T, et al
    Evaluating emergency-release blood transfusion of newborn infants at the Intermountain Healthcare hospitals.
    Transfusion. 2019 Sep 3. doi: 10.1111/trf.15495.
    >> Share

    June 2019
  68. KAMYSZEK RW, Raval JS, Srinivasan AJ, Ansari AK, et al
    Interval decline in hemoglobin A is associated with annual clinical event rate in sickle cell anemia patients receiving maintenance apheresis RBC exchange.
    Transfusion. 2019 Jun 3. doi: 10.1111/trf.15386.
    >> Share

    May 2019
  69. MILLER J, Cai W, Andrews J, Narla A, et al
    A case series of pediatric patients with direct antiglobulin test negative autoimmune hemolytic anemia.
    Transfusion. 2019 May 21. doi: 10.1111/trf.15350.
    >> Share

  70. VISAGIE M, Pearson KR, Purvis TE, Gehrie EA, et al
    Greater anemia tolerance among hospitalized females compared to males.
    Transfusion. 2019 May 7. doi: 10.1111/trf.15338.
    >> Share

    March 2019
  71. ARTHUR CM, Nalbant D, Feldman HA, Saeedi BJ, et al
    Anemia induces gut inflammation and injury in an animal model of preterm infants.
    Transfusion. 2019 Mar 21. doi: 10.1111/trf.15254.
    >> Share

  72. BURGOS PRATX L, Santoro D, Coca Mogro B, Valiente VL, et al
    Etoricoxib-induced immune hemolytic anemia: first case presenting acute kidney failure.
    Transfusion. 2019 Mar 13. doi: 10.1111/trf.15226.
    >> Share

  73. SHEHATA N, Mazer CD
    Red cell transfusion in cardiac surgery: what is the right balance?
    Transfusion. 2019;59:903-904.
    >> Share

    February 2019
  74. HEQUET O, Poutrel S, Connes P, Revesz D, et al
    Automatic depletion with Spectra Optia allows a safe 16% reduction of red blood cell pack consumption in exchanged sickle cell anemia patients.
    Transfusion. 2019 Feb 12. doi: 10.1111/trf.15188.
    >> Share

  75. DESIMONE RA, Ong SJ, Crowley KM, Vasovic LV, et al
    Hereditary elliptocytosis of donor red blood cell unit detected during Coombs crossmatch.
    Transfusion. 2019;59:446-447.
    >> Share

  76. MURPHY C, Parakh R, Metcalf R, Pagano MB, et al
    Transfusion-associated chest pain.
    Transfusion. 2019;59:463-469.
    >> Share

  77. DEAN CL, Maier CL, Roback JD, Stowell SR, et al
    Multiple hemolytic transfusion reactions misinterpreted as severe vaso-occlusive crisis in a patient with sickle cell disease.
    Transfusion. 2019;59:448-453.
    >> Share

    January 2019
  78. QUINTANILLA-BORDAS C, Castro-Izaguirre E, Carcelen-Gadea M, Marin M, et al
    The first reported case of drug-induced hemolytic anemia caused by dimethyl fumarate in a patient with multiple sclerosis.
    Transfusion. 2019 Jan 31. doi: 10.1111/trf.15151.
    >> Share

  79. ROMPHRUK AV, Simtong P, Butryojantho C, Pimphumee R, et al
    The prevalence, alloimmunization risk factors, antigenic exposure, and evaluation of antigen-matched red blood cells for thalassemia transfusions: a 10-year experience at a tertiary care hospital.
    Transfusion. 2019;59:177-184.
    >> Share

  80. PAVENSKI K, Ward SE, Hare GMT, Freedman J, et al
    A rationale for universal tranexamic acid in major joint arthroplasty: overall efficacy and impact of risk factors for transfusion.
    Transfusion. 2019;59:207-216.
    >> Share

    December 2018
  81. LI S, Mo C, Huang L, Shi X, et al
    Hemolytic disease of the fetus and newborn due to alloanti-M: three Chinese case reports and a review of the literature.
    Transfusion. 2018 Dec 6. doi: 10.1111/trf.15054.
    >> Share

  82. ANLIKER M, Schmidt CQ, Harder MJ, Ganchev G, et al
    Complement activation by human red blood cell antibodies: hemolytic potential of antibodies and efficacy of complement inhibitors assessed by a sensitive flow cytometric assay.
    Transfusion. 2018;58:2992-3002.
    >> Share

  83. SIMMONDS MJ, Suriany S, Ponce D, Detterich JA, et al
    Red blood cell mechanical sensitivity improves in patients with sickle cell disease undergoing chronic transfusion after prolonged, subhemolytic shear exposure.
    Transfusion. 2018;58:2788-2796.
    >> Share

  84. CULP-HILL R, Srinivasan AJ, Gehrke S, Kamyszek R, et al
    Effects of red blood cell (RBC) transfusion on sickle cell disease recipient plasma and RBC metabolism.
    Transfusion. 2018;58:2797-2806.
    >> Share

  85. LAL A, Wong TE, Andrews J, Balasa VV, et al
    Transfusion practices and complications in thalassemia.
    Transfusion. 2018;58:2826-2835.
    >> Share

    November 2018
  86. FONTANALS M, O'Leary JD, Zaarour C, Skelton T, et al
    Preoperative anemia increases the risk of red blood cell transfusion and prolonged hospital length of stay in children undergoing spine arthrodesis surgery.
    Transfusion. 2018 Nov 30. doi: 10.1111/trf.15055.
    >> Share

  87. RUSSELL L, Holst LB, Lange T, Liang X, et al
    Effects of anemia and blood transfusion on clot formation and platelet function in patients with septic shock: a substudy of the randomized TRISS trial.
    Transfusion. 2018 Nov 5. doi: 10.1111/trf.14904.
    >> Share

  88. ALLEN ES, Nelson RC, Flegel WA
    How we evaluate red blood cell compatibility and transfusion support for patients with sickle cell disease undergoing hematopoietic progenitor cell transplantation.
    Transfusion. 2018;58:2483-2489.
    >> Share

  89. LEMAY AS, Tong TN, Branch DR, Huang M, et al
    The first case of severe acute hemolytic transfusion reaction caused by anti-Sc2.
    Transfusion. 2018;58:2506-2512.
    >> Share

    October 2018
  90. FURUI Y, Yamagishi N, Morioka I, Taira R, et al
    Sequence analyses of variable cytomegalovirus genes for distinction between breast milk- and transfusion-transmitted infections in very-low-birth-weight infants.
    Transfusion. 2018 Oct 19. doi: 10.1111/trf.14920.
    >> Share

  91. GIJTENBEEK M, Lopriore E, Steggerda SJ, Te Pas AB, et al
    Persistent pulmonary hypertension of the newborn after fetomaternal hemorrhage.
    Transfusion. 2018 Oct 13. doi: 10.1111/trf.14932.
    >> Share

  92. MENCHETTI I, Lin Y, Cserti-Gazdewich C, Goldstein J, et al
    Complications of a severe autoimmune hemolytic anemia crisis: transfusional iron overload and gangrenous cholecystitis.
    Transfusion. 2018 Oct 6. doi: 10.1111/trf.14888.
    >> Share

  93. KRISHNASIVAM D, Trentino KM, Burrows S, Farmer SL, et al
    Anemia in hospitalized patients: an overlooked risk in medical care.
    Transfusion. 2018 Oct 1. doi: 10.1111/trf.14877.
    >> Share

  94. WILSON MJ, Koopman-van Gemert AWMM, Harlaar JJ, Jeekel J, et al
    Patient blood management in colorectal cancer patients: a survey among Dutch gastroenterologists, surgeons, and anesthesiologists.
    Transfusion. 2018;58:2345-2351.
    >> Share

  95. WARKENTIN TE, Morin PA, Heddle NM
    Neutropenia and monocytopenia in recurrent anaphylactoid reactions after red blood cell transfusions in a woman with immunoglobulin A (IgA) deficiency and anti-IgA.
    Transfusion. 2018;58:2320-2325.
    >> Share

    September 2018
  96. NOLAN BE, Wang Y, Pary PP, Luban NLC, et al
    High-dose intravenous immunoglobulin is strongly associated with hemolytic anemia in patients with Kawasaki disease.
    Transfusion. 2018 Sep 28. doi: 10.1111/trf.14879.
    >> Share

  97. HESS J, Su L, Nizzi F, Beebe K, et al
    Successful treatment of severe refractory autoimmune hemolytic anemia after hematopoietic stem cell transplant with abatacept.
    Transfusion. 2018 Sep 4. doi: 10.1111/trf.14907.
    >> Share

  98. GOCKE CB, Shanbhag S
    Neutrophil-red blood cell rosetting in a patient with autoimmune hemolytic anemia.
    Transfusion. 2018;58:2102-2103.
    >> Share

  99. ANAND A, Mace KE, Townsend RL, Madison-Antenucci S, et al
    Investigation of a case of suspected transfusion-transmitted malaria.
    Transfusion. 2018;58:2115-2121.
    >> Share

  100. MAURIN C, Vassal O, Darien M, Raba M, et al
    Immune hemolysis secondary to injection of contrast medium.
    Transfusion. 2018;58:2113-2114.
    >> Share

  101. BLOCH EM, Ingram C, Hull J, Fawcus S, et al
    Risk factors for peripartum blood transfusion in South Africa: a case-control study.
    Transfusion. 2018;58:2149-2156.
    >> Share

  102. VIANELLO A, Vencato E, Cantini M, Zanconato G, et al
    Improvement of maternal and fetal outcomes in women with sickle cell disease treated with early prophylactic erythrocytapheresis.
    Transfusion. 2018;58:2192-2201.
    >> Share

    August 2018
  103. NIXON CP, Sweeney JD
    Severe iron deficiency anemia: red blood cell transfusion or intravenous iron?
    Transfusion. 2018;58:1824-1826.
    >> Share

  104. BILLER E, Zhao Y, Berg M, Boggio L, et al
    Red blood cell exchange in patients with sickle cell disease-indications and management: a review and consensus report by the therapeutic apheresis subsection of the AABB.
    Transfusion. 2018;58:1965-1972.
    >> Share

    July 2018
  105. WIN N, Needs M, Thornton N, Webster R, et al
    Transfusions of least-incompatible blood with intravenous immunoglobulin plus steroids cover in two patients with rare antibody.
    Transfusion. 2018;58:1626-1630.
    >> Share

  106. CAMPBELL-LEE SA, Gvozdjan K, Choi KM, Chen YF, et al
    Red blood cell alloimmunization in sickle cell disease: assessment of transfusion protocols during two time periods.
    Transfusion. 2018;58:1588-1596.
    >> Share

    June 2018
  107. FLOCH A, Gien D, Tournamille C, Chami B, et al
    High immunogenicity of red blood cell antigens restricted to the population of African descent in a cohort of sickle cell disease patients.
    Transfusion. 2018;58:1527-1535.
    >> Share

  108. COMPERNOLLE V, Chou ST, Tanael S, Savage W, et al
    Red blood cell specifications for patients with hemoglobinopathies: a systematic review and guideline.
    Transfusion. 2018;58:1555-1566.
    >> Share

  109. DEDEKEN L, Le PQ, Rozen L, El Kenz H, et al
    Automated RBC exchange compared to manual exchange transfusion for children with sickle cell disease is cost-effective and reduces iron overload.
    Transfusion. 2018;58:1356-1362.
    >> Share

  110. MAIER CL, Gross PJ, Dean CL, Chonat S, et al
    Transfusion-transmitted malaria masquerading as sickle cell crisis with multisystem organ failure.
    Transfusion. 2018;58:1550-1554.
    >> Share

    May 2018
  111. GUINN NR, Cooter ML, Villalpando C, Weiskopf RB, et al
    Severe anemia associated with increased risk of death and myocardial ischemia in patients declining blood transfusion.
    Transfusion. 2018 May 24. doi: 10.1111/trf.14768.
    >> Share

  112. AHMAD I, Majeed Memon A, Moiz B
    Mixed IgM cold and IgG warm autoimmune hemolytic anemia complicated by acral gangrene.
    Transfusion. 2018;58:1093-1094.
    >> Share

    April 2018
  113. YEE MEM, Josephson CD, Winkler AM, Webb J, et al
    Hemoglobin A clearance in children with sickle cell anemia on chronic transfusion therapy.
    Transfusion. 2018 Apr 17. doi: 10.1111/trf.14610.
    >> Share

  114. KHADADAH F, Callum J, Shelton D, Lin Y, et al
    Improving quality of care for patients with iron deficiency anemia presenting to the emergency department.
    Transfusion. 2018 Apr 17. doi: 10.1111/trf.14626.
    >> Share

  115. MINAKAWA K, Ohto H, Yasuda H, Saito S, et al
    Efficacy of D- red blood cell transfusion and rituximab therapy in autoimmune hemolytic anemia with anti-D and panreactive autoantibodies arising after hematopoietic stem cell transplant.
    Transfusion. 2018 Apr 17. doi: 10.1111/trf.14634.
    >> Share

  116. STEPHAN C, Phulpin A, Steschenko D, Lesesve JF, et al
    Oxidative stress-related infantile pyknocytosis with Heinz bodies.
    Transfusion. 2018;58:840-841.
    >> Share

  117. SCHREIBER GB, Brinser R, Rosa-Bray M, Yu ZF, et al
    Frequent source plasma donors are not at risk of iron depletion: the Ferritin Levels in Plasma Donor (FLIPD) study.
    Transfusion. 2018;58:951-959.
    >> Share

  118. VAN BUREN NL, Gorlin JB, Reed RC, Gottschall JL, et al
    Ceftriaxone-induced drug reaction mimicking acute splenic sequestration crisis in a child with hemoglobin SC disease.
    Transfusion. 2018;58:879-883.
    >> Share

  119. GYBEL-BRASK M, Seeberg J, Thomsen LL, Johansson PI, et al
    Intravenous iron isomaltoside improves hemoglobin concentration and iron stores in female iron-deficient blood donors: a randomized double-blind placebo-controlled clinical trial.
    Transfusion. 2018;58:974-981.
    >> Share

  120. AL-RIYAMI AZ, Al-Muqbali A, Al-Sudiri S, Murthi Panchatcharam S, et al
    Risks of red blood cell alloimmunization in transfusion-dependent beta-thalassemia in Oman: a 25-year experience of a university tertiary care reference center and a literature review.
    Transfusion. 2018;58:871-878.
    >> Share

    March 2018
  121. DE LAS NIEVES LOPEZ MA, Matas Cobos AM, Sarria Gonzalez F, Dominguez Lomena MJ, et al
    Red blood cell transfusion after a global strategy for early detection and treatment of iron deficiency anemia: three-year results of a prospective observational study.
    Transfusion. 2018 Mar 26. doi: 10.1111/trf.14582.
    >> Share

  122. SCHOTTEN N, Zalpuri S, Pasker-de Jong PCM, Swinkels DW, et al
    Utility of zinc protoporphyrin in management of whole blood donors.
    Transfusion. 2018;58:692-700.
    >> Share

  123. BENNETT S, Ayoub A, Tran A, English S, et al
    Current practices in perioperative blood management for patients undergoing liver resection: a survey of surgeons and anesthesiologists.
    Transfusion. 2018;58:781-787.
    >> Share

  124. IGARASHI T, Fujita H, Asaka H, Takada Y, et al
    Patient rescue and blood utilization in the Ogasawara blood rotation system.
    Transfusion. 2018;58:788-794.
    >> Share

  125. MWESIGWA S, Moulds JM, Chen A, Flanagan J, et al
    Whole-exome sequencing of sickle cell disease patients with hyperhemolysis syndrome suggests a role for rare variation in disease predisposition.
    Transfusion. 2018;58:726-735.
    >> Share

    February 2018
  126. TOLY-NDOUR C, Mourtada H, Huguet-Jacquot S, Maisonneuve E, et al
    Clinical input of anti-D quantitation by continuous-flow analysis on autoanalyzer in the management of high-titer anti-D maternal alloimmunization.
    Transfusion. 2018;58:294-305.
    >> Share

  127. SEIELSTAD M, Page GP, Gaddis N, Lanteri M, et al
    Genomewide association study of HLA alloimmunization in previously pregnant blood donors.
    Transfusion. 2018;58:402-412.
    >> Share

    January 2018
  128. APATA IW, Drammeh B, De AK, Bjork A, et al
    Diagnoses and ordering practices driving blood demand for treatment of anemia in Tanzania.
    Transfusion. 2018 Jan 19. doi: 10.1111/trf.14461.
    >> Share

  129. DAS S, Kumar V, Jafa E, Basavarajegowda A, et al
    Complete disappearance of ABO antigen-a cause of ABO discrepancy.
    Transfusion. 2018;58:5-6.
    >> Share

  130. CHAN KLL, Mak WMV, Tam YH, Lee KKH, et al
    Factors affecting patient-reported outcomes after red blood cell transfusion in medical patients.
    Transfusion. 2018;58:158-167.
    >> Share

  131. DAVIS JM, El-Haj N, Shah NN, Schwartz G, et al
    Use of the blood substitute HBOC-201 in critically ill patients during sickle crisis: a three-case series.
    Transfusion. 2018;58:132-137.
    >> Share

  132. KELLER J, Vege S, Horn T, Keller MA, et al
    Novel mutations in KLF1 encoding the In(Lu) phenotype reflect a diversity of clinical presentations.
    Transfusion. 2018;58:196-199.
    >> Share

  133. MATHUR G, Ten Eyck P, Knudson CM
    Predicting changes in hemoglobin S after simple transfusion using complete blood counts.
    Transfusion. 2018;58:138-144.
    >> Share

    December 2017
  134. WILSON MJ, Dekker JW, Bruns E, Borstlap W, et al
    Short-term effect of preoperative intravenous iron therapy in colorectal cancer patients with anemia: results of a cohort study.
    Transfusion. 2017 Dec 17. doi: 10.1111/trf.14456.
    >> Share

  135. PETTY K, Waters JH, Sakamoto SB, Yazer MH, et al
    Antenatal anemia increases the risk of receiving postpartum red blood cell transfusions although the overall risk of transfusion is low.
    Transfusion. 2017 Dec 1. doi: 10.1111/trf.14434.
    >> Share

    November 2017
  136. PUJOL-NICOLAS A, Morrison R, Casson C, Khan S, et al
    Preoperative screening and intervention for mild anemia with low iron stores in elective hip and knee arthroplasty.
    Transfusion. 2017 Nov 6. doi: 10.1111/trf.14372.
    >> Share

    October 2017
  137. NEDELCU E, Desai M, Green J, Bensing KM, et al
    Acute autoimmune hemolytic anemia due to anti-Ena autoantibody successfully treated with rituximab.
    Transfusion. 2017 Oct 11. doi: 10.1111/trf.14363.
    >> Share

  138. GNIADEK TJ, Arndt PA, Leger RM, Zydowicz D, et al
    Drug-induced immune hemolytic anemia associated with anti-vancomycin complicated by a paraben antibody.
    Transfusion. 2017 Oct 8. doi: 10.1111/trf.14362.
    >> Share

  139. AMREIN K, Macher S, Schrock M, Schlenke P, et al
    Iron deficiency in blood donors: perceptions and management among general practitioners and internists.
    Transfusion. 2017;57:2548-2549.
    >> Share

  140. YOUSSEF LA, Spitalnik SL
    Iron: a double-edged sword.
    Transfusion. 2017;57:2293-2297.
    >> Share

    September 2017
  141. LINNIK YA, Tsui EW, Martin IW, Szczepiorkowski ZM, et al
    The first reported case of concurrent trimethoprim-sulfamethoxazole-induced immune hemolytic anemia and thrombocytopenia.
    Transfusion. 2017 Sep 14. doi: 10.1111/trf.14315.
    >> Share

  142. PIETY NZ, Reinhart WH, Stutz J, Shevkoplyas SS, et al
    Optimal hematocrit in an artificial microvascular network.
    Transfusion. 2017;57:2257-2266.
    >> Share

  143. GEHRIE EA, Ness PM, Bloch EM, Kacker S, et al
    Medical and economic implications of strategies to prevent alloimmunization in sickle cell disease.
    Transfusion. 2017;57:2267-2276.
    >> Share

  144. BALLAS SK
    From total blood exchange to erythrocytapheresis and back to treat complications of sickle cell disease.
    Transfusion. 2017;57:2277-2280.
    >> Share

    August 2017
  145. YEE MEM, Josephson CD, Winkler AM, Webb J, et al
    Red blood cell minor antigen mismatches during chronic transfusion therapy for sickle cell anemia.
    Transfusion. 2017 Aug 24. doi: 10.1111/trf.14282.
    >> Share

  146. LASO-MORALES M, Jerico C, Gomez-Ramirez S, Castellvi J, et al
    Preoperative management of colorectal cancer-induced iron deficiency anemia in clinical practice: data from a large observational cohort.
    Transfusion. 2017 Aug 21. doi: 10.1111/trf.14278.
    >> Share

  147. YADAV S, Shetty S, Kulkarni B
    A novel homozygous frameshift mutation in Exon 7 of the ADAMTS13 gene in a patient with congenital thrombotic thrombocytopenic purpura from India: a case report.
    Transfusion. 2017 Aug 21. doi: 10.1111/trf.14279.
    >> Share

    July 2017
  148. BAILEN R, Kwon M, Perez-Corral AM, Pascual C, et al
    Transient hemolysis due to anti-D and anti-A1 produced by engrafted donor's lymphocytes after allogeneic unmanipulated haploidentical hematopoietic stem cell transplantation.
    Transfusion. 2017 Jul 13. doi: 10.1111/trf.14232.
    >> Share

  149. KISS JE, Birch RJ, Steele WR, Wright DJ, et al
    Quantification of body iron and iron absorption in the REDS-II Donor Iron Status Evaluation (RISE) study.
    Transfusion. 2017;57:1656-1664.
    >> Share

    June 2017
  150. SUFFREDINI DA, Xu W, Sun J, Barea-Mendoza J, et al
    Parenteral irons versus transfused red blood cells for treatment of anemia during canine experimental bacterial pneumonia.
    Transfusion. 2017 Jun 27. doi: 10.1111/trf.14214.
    >> Share

  151. ANANI W, Wucinski J, Baumann Kreuziger L, Gottschall J, et al
    Therapeutic plasma exchange in refractory warm autoimmune hemolytic anemia.
    Transfusion. 2017;57:1336.
    >> Share

  152. WILEN CB, Booth GS, Grossman BJ, Lane WJ, et al
    Using direct antiglobulin test results to reduce unnecessary cold agglutinin testing.
    Transfusion. 2017;57:1480-1484.
    >> Share

    Kids, colds, and complement: paroxysmal cold hemoglobinuria.
    Transfusion. 2017;57:1332-1335.
    >> Share

    May 2017
  154. HULBERT ML, Panepinto JA, Scott JP, Liem RI, et al
    Red blood cell transfusions during sickle cell anemia vaso-occlusive crises: a report from the magnesium in crisis (MAGiC) study.
    Transfusion. 2017 May 12. doi: 10.1111/trf.14155.
    >> Share

  155. GNIADEK TJ, McGonigle AM, Shirey RS, Brunker PA, et al
    A rare, potentially life-threatening presentation of passenger lymphocyte syndrome.
    Transfusion. 2017;57:1262-1266.
    >> Share

  156. GRENINGER AL, Hess JR
    Clostridium perfringens sepsis masquerading as a hemolytic transfusion reaction.
    Transfusion. 2017;57:1112.
    >> Share

    April 2017
  157. BISWAS A, Firdaus R, Gupta D, Ghosh M, et al
    Interferon lambda3 gene (IL28B) is associated with spontaneous or treatment-induced viral clearance in hepatitis C virus-infected multitransfused patients with thalassemia.
    Transfusion. 2017 Apr 16. doi: 10.1111/trf.14070.
    >> Share

  158. GOEL R, Snow J, Pri-Paz SM, Cushing M, et al
    Intrauterine transfusions for severe fetal anemia and hydrops due to de novo epsilongammadeltabeta-thalassemia.
    Transfusion. 2017;57:876.
    >> Share

  159. GHESQUIERE L, Houfflin-Debarge V, Behal H, Coulon C, et al
    Should optimal timing between two intrauterine transfusions be based on estimated daily decrease of hemoglobin or on measurement of fetal middle cerebral artery peak systolic velocity?
    Transfusion. 2017;57:899-904.
    >> Share

    March 2017
  160. PRINCE SD, Winestone LE, Nance SJ, Friedman DF, et al
    Recurrent Donath-Landsteiner hemolytic anemia: a pediatric case report.
    Transfusion. 2017 Mar 31. doi: 10.1111/trf.14032.
    >> Share

  161. RAUCH S, Ritgen J, Wisskirchen M, Bauerfeind U, et al
    A case of anti-Rd causing fetal anemia.
    Transfusion. 2017 Mar 7. doi: 10.1111/trf.14078.
    >> Share

  162. DELANEY M, Wikman A, van de Watering L, Schonewille H, et al
    Blood Group Antigen Matching Influence on Gestational Outcomes (AMIGO) study.
    Transfusion. 2017;57:525-532.
    >> Share

  163. ODUOR H, Minniti CP, Brofferio A, Gharib AM, et al
    Severe cardiac iron toxicity in two adults with sickle cell disease.
    Transfusion. 2017;57:700-704.
    >> Share

  164. MAST AE
    Putting donor health first in strategies to mitigate donor iron deficiency.
    Transfusion. 2017;57:495-498.
    >> Share

  165. LOPEZ GH, Wilson B, Liew YW, Kupatawintu P, et al
    An alloantibody in a homozygous GYP*Mur individual defines JENU (MNS49), a new high-frequency antigen on glycophorin B.
    Transfusion. 2017;57:716-717.
    >> Share

    February 2017
  166. ZIMAN A, Cohn C, Carey PM, Dunbar NM, et al
    Warm-reactive (immunoglobulin G) autoantibodies and laboratory testing best practices: review of the literature and survey of current practice.
    Transfusion. 2017;57:463-477.
    >> Share

  167. SIPPERT EA, Visentainer JE, Alves HV, Rodrigues C, et al
    Red blood cell alloimmunization in patients with sickle cell disease: correlation with HLA and cytokine gene polymorphisms.
    Transfusion. 2017;57:379-389.
    >> Share

  168. AL-JADA NA
    A Jordanian family with three sisters apparently homozygous for Mk and evidence for clinical significance of antibodies produced by Mk Mk individuals.
    Transfusion. 2017;57:376-378.
    >> Share

    January 2017
  169. PRABHU M, Bateman BT
    Postpartum anemia: missed opportunities for prevention and recognition.
    Transfusion. 2017;57:3-5.
    >> Share

  170. ZELLER MP, Arnold DM, Al Habsi K, Cserti-Gazdewich C, et al
    Paroxysmal cold hemoglobinuria: a difficult diagnosis in adult patients.
    Transfusion. 2017;57:137-143.
    >> Share

    December 2016
  171. KROMKER M, Lauscher P, Kertscho H, Zacharowski K, et al
    Anemia tolerance during normo-, hypo-, and hypervolemia.
    Transfusion. 2016 Dec 19. doi: 10.1111/trf.13942.
    >> Share

  172. STYRON JF, Klika AK, Szubski CR, Tolich D, et al
    Relative efficacy of tranexamic acid and preoperative anemia treatment for reducing transfusions in total joint arthroplasty.
    Transfusion. 2016 Dec 17. doi: 10.1111/trf.13955.
    >> Share

  173. CONSTANTINOU VC, Bouinta A, Karponi G, Zervou F, et al
    Poor stem cell harvest may not always be related to poor mobilization: lessons gained from a mobilization study in patients with beta-thalassemia major.
    Transfusion. 2016 Dec 17. doi: 10.1111/trf.13951.
    >> Share

    November 2016
  174. WEISKOPF RB, Beliaev AM, Shander A, Guinn NR, et al
    Addressing the unmet need of life-threatening anemia with hemoglobin-based oxygen carriers.
    Transfusion. 2016 Nov 18. doi: 10.1111/trf.13923.
    >> Share

    September 2016
  175. BUTWICK AJ, Walsh EM, Kuzniewicz M, Li SX, et al
    Patterns and predictors of severe postpartum anemia after Cesarean section.
    Transfusion. 2016 Sep 13. doi: 10.1111/trf.13815.
    >> Share

  176. LAKKARAJA M, Jin JC, Manotas KC, Vinograd CA, et al
    Blood group A mothers are more likely to develop anemia during antenatal intravenous immunoglobulin treatment of fetal and neonatal alloimmune thrombocytopenia.
    Transfusion. 2016 Sep 9. doi: 10.1111/trf.13779.
    >> Share

  177. MUNOZ M, Gomez-Ramirez S, Auerbach M
    Stimulating erythropoiesis before hip fracture repair for reducing blood transfusion: should we change the hemoglobin cutoff level for defining anemia in females?
    Transfusion. 2016;56:2160-3.
    >> Share

    August 2016
  178. GERMAIN M, Delage G, Robillard P, Katz LM, et al
    The association between frequency of blood donation and the occurrence of low birthweight, preterm delivery, and stillbirth: a retrospective cohort study.
    Transfusion. 2016 Aug 11. doi: 10.1111/trf.13762.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016